| 000 | 01723 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250518013428.0 | ||
| 264 | 0 | _c20191104 | |
| 008 | 201911s 0 0 eng d | ||
| 022 | _a2044-6055 | ||
| 024 | 7 |
_a10.1136/bmjopen-2018-022613 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJoshy, Grace | |
| 245 | 0 | 0 |
_aPredicting 7-year mortality for use with evidence-based guidelines for Prostate-Specific Antigen (PSA) testing: findings from a large prospective study of 123 697 Australian men. _h[electronic resource] |
| 260 |
_bBMJ open _c12 2018 |
||
| 300 |
_ae022613 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aCause of Death |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDisability Evaluation |
| 650 | 0 | 4 | _aEarly Detection of Cancer |
| 650 | 0 | 4 | _aEarly Diagnosis |
| 650 | 0 | 4 | _aEarly Medical Intervention |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aGuideline Adherence |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKallikreins _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNew South Wales |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xmortality |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aBanks, Emily | |
| 700 | 1 | _aLowe, Anthony | |
| 700 | 1 | _aWolfe, Rory | |
| 700 | 1 | _aTickle, Leonie | |
| 700 | 1 | _aArmstrong, Bruce | |
| 700 | 1 | _aClements, Mark | |
| 773 | 0 |
_tBMJ open _gvol. 8 _gno. 12 _gp. e022613 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmjopen-2018-022613 _zAvailable from publisher's website |
| 999 |
_c29165137 _d29165137 |
||